Conciseness

Largely lean with terse phase summaries and bullet lists, but the seven-item KEY PRINCIPLES and detailed Naranjo algorithm walkthrough include some explanation that could be trimmed; efficient yet slightly above the leanest anchor.

Actionability

Provides concrete tool names, explicit signal criteria (PRR >= 2.0, lower CI > 1.0, N >= 3), strength thresholds, and scoring components, but defers most executable code to PHASE_DETAILS.md rather than including copy-paste examples inline.

Workflow Clarity

A clear ten-phase sequence is laid out with an ASCII diagram, Phase 2 flagged as CRITICAL, and an Edge Cases section, but validation checkpoints are mostly implicit (report-first principle, completeness checklist) rather than explicit validate-then-proceed loops.

Progressive Disclosure

The body signals one-level-deep references to PHASE_DETAILS.md, REPORT_TEMPLATE.md, TOOL_REFERENCE.md, and QUICK_START.md, but none of these bundle files actually exist in the directory, breaking the navigation it advertises.

Specificity

Lists multiple concrete actions ('Detect and analyze adverse drug event signals', 'Generates quantitative safety signal scores (0-100) with evidence grading') and names specific methods (PRR, ROR, IC), giving comprehensive coverage of capabilities.

Completeness

Explicitly answers both 'what' (detect, analyze, score, grade signals) and 'when' via a concrete 'Use for ...' trigger clause listing multiple applicable scenarios.

Trigger Term Quality

Covers comprehensive natural terms users would say — 'post-market surveillance', 'pharmacovigilance', 'drug safety assessment', 'regulatory submissions', 'FAERS reports', plus synonyms (adverse drug event / AE) — matching the top anchor.

Distinctiveness Conflict Risk

Occupies a clear niche (FAERS disproportionality-based adverse-event signal detection with a 0-100 Safety Signal Score) with domain-specific triggers and minimal overlap with unrelated skills.